DaVita misses quarterly profit estimates on rising costs, lower volumes

Core Viewpoint - DaVita missed Wall Street estimates for third-quarter profit due to rising patient care costs and declining treatment volumes [1] Company Summary - DaVita is facing challenges with increasing costs associated with patient care [1] - The company reported a decline in treatment volumes, which has negatively impacted its financial performance [1] Industry Summary - The kidney dialysis industry is experiencing pressures from rising operational costs and a potential decrease in patient treatment frequency [1]